about
PPAR-gamma: Therapeutic Potential for Multiple SclerosisEpidemiologic evidence for multiple sclerosis as an infectionOmega-3 fatty acid supplementation decreases matrix metalloproteinase-9 production in relapsing-remitting multiple sclerosisCD4+CD28- costimulation-independent T cells in multiple sclerosisVirus-mediated autoimmunity in Multiple Sclerosis.Immunosuppressive, anti-inflammatory and anti-cancer properties of triptolide: A mini reviewTherapeutic potential of mesenchymal stem cells for oral and systemic diseasesPositive or negative involvement of heat shock proteins in multiple sclerosis pathogenesis: an overviewScience gone translational: the OX40 agonist storyIn Vivo Quantification of Inflammation in Experimental Autoimmune Encephalomyelitis Rats Using Fluorine-19 Magnetic Resonance Imaging Reveals Immune Cell Recruitment outside the Nervous SystemLive Imaging of Immune Responses in Experimental Models of Multiple SclerosisTreatment of multiple sclerosis with cyclophosphamide: critical review of clinical and immunologic effectsInfluence of FK 506 (tacrolimus) on circulating CD4+ T cells expressing CD25 and CD45RA antigens in 19 patients with chronic progressive multiple sclerosis participating in an open label drug safety trialInvolvement of tissue plasminogen activator in onset and effector phases of experimental allergic encephalomyelitisAbsence of monocyte chemoattractant protein 1 in mice leads to decreased local macrophage recruitment and antigen-specific T helper cell type 1 immune response in experimental autoimmune encephalomyelitisGlyconanoparticles allow pre-symptomatic in vivo imaging of brain diseaseA molecular view of multiple sclerosis and experimental autoimmune encephalitis: what can we learn from the epitope data?Microstructural origins of gadolinium-enhanced susceptibility contrast and anisotropyPredicting relapsing-remitting dynamics in multiple sclerosis using discrete distribution models: a population approach.Interferon-gamma protects astrocytes from apoptosis and increases the formation of p21ras-GTP complex through ras oncogene family overexpression.Isolation and characterization of an oligodendrocyte precursor-derived B-cell epitope in multiple sclerosis.Cleavage of transaldolase by granzyme B causes the loss of enzymatic activity with retention of antigenicity for multiple sclerosis patients.Molecular mimicry and multiple sclerosis: degenerate T-cell recognition and the induction of autoimmunity.Cyclopentenone prostaglandins PGA2 and 15-deoxy-delta12,14 PGJ2 suppress activation of murine microglia and astrocytes: implications for multiple sclerosis.Nuclear receptors and autoimmune disease: the potential of PPAR agonists to treat multiple sclerosis.A comparative study of experimental mouse models of central nervous system demyelination.Direct evidence for limited clonality of antibodies to glutamic acid decarboxylase (GAD) in stiff man syndrome using baculovirus expressed GADInterferon-gamma activated calcium influx in peripheral blood lymphocytes from patients with primary and secondary progressive multiple sclerosisQuantitation of spinal cord demyelination, remyelination, atrophy, and axonal loss in a model of progressive neurologic injury.Shifts in the epitopes of myelin basic protein recognized by Lewis rat T cells before, during, and after the induction of experimental autoimmune encephalomyelitisMyelin basic protein-specific T lymphocyte repertoire in multiple sclerosis. Complexity of the response and dominance of nested epitopes due to recruitment of multiple T cell clonesThe transmembrane adapter protein SIT regulates thymic development and peripheral T-cell functions.Modeling the effector - regulatory T cell cross-regulation reveals the intrinsic character of relapses in Multiple SclerosisImmune regulation of multiple sclerosis by CD8+ T cellsIn vivo imaging of lymphocytes in the CNS reveals different behaviour of naïve T cells in health and autoimmunity.Cortical injury in multiple sclerosis; the role of the immune system.Anti-DNA antibodies are a major component of the intrathecal B cell response in multiple sclerosis.Identification of alpha-tropomyosin as a target self-antigen in Behçet's syndrome.Discrepancy in CCL2 and CCR2 expression in white versus grey matter hippocampal lesions of Multiple Sclerosis patients.Treatment of multiple sclerosis with the pregnancy hormone estriol.
P2860
Q21342822-59F5CF69-0A4A-4E99-A90D-FFF71EB9B27FQ24615844-01D8FC10-1A8E-4DD1-9D9C-0BE3084A0F07Q24649574-37D8A8AB-7175-4661-B318-7AFC36AF20C4Q24670063-9298829A-8FB5-4966-BAD6-A1285BBC8250Q25256901-E145B95B-DAFF-45CA-A373-137DF2D2D91AQ26746015-7CE2F2EE-6BA2-4268-AC77-94B846F0FC4BQ26991746-BE3D0DA9-028C-498E-8EF3-8591145F045AQ27000682-B866BEAD-4E54-4787-9E7E-CD5504C346B5Q27022436-B0A800B5-1D2E-476B-A0C0-C20AC8ABCB85Q27313901-06D086A8-EF48-43F4-ACE3-1F2AE34532C9Q28075478-7FAB701D-39C9-4B5B-ADDE-DFEC8A823026Q28216546-30E74DCE-720A-4A61-B71F-1F7550A2E592Q28367696-C10B9029-2193-47C8-9813-9A45BB695B05Q28505308-6A27D755-E4C9-4119-8CD7-73D65F45D087Q28755978-5261C025-2BB8-4697-A134-9CE69B4CB000Q30485161-04C9AE37-64F3-49B4-934F-6B5D5C0E30F2Q30723942-6EAA56DD-6102-40B7-AD81-1AD7A44258C6Q30737435-6BDA9587-0FD1-4ACB-BDB6-A5BE6A6EC348Q31138740-9D2D4D8B-5191-4B0C-B968-E5B0B95971EFQ31949267-8F2C8703-3B50-4679-82AD-409D9DA3F3E3Q32133808-FC8370FC-45F6-402D-9C48-E6F4B621C551Q33535660-95582DF1-78B7-443D-9955-50DB890F478FQ33630981-AF126FBB-06DB-48DE-A31D-0AD9B7412D63Q33644063-E72295D2-FCCB-4D1C-9A97-5C5BE3745799Q33644094-008CFCE5-A353-40E7-95DB-91F025461A78Q33717475-4912731E-10E6-4B50-A8BC-06E73591CCEDQ33732542-E08F84A8-C11F-4EA8-A163-5DA0D8482272Q33735608-FE0C39CB-EA97-4FCB-8660-8FCF55CD7C94Q33746036-430148C0-41D2-4C45-83C8-7041714385F0Q33907293-B37BE717-3E99-4939-95DD-AF86978DEB79Q33909622-482BE64C-7747-4BCC-9140-CF00A36CB5B5Q33925131-302D5AD6-6ABD-4C8F-8735-D12387B4F341Q33962548-BEEED14B-9F24-412D-81B5-4D25B24F8F52Q34017004-5E1CAE76-6952-481B-B2D1-0ACAEC6E53D2Q34042100-EE2EDEAA-42FF-4172-BBC6-62761EE5FA51Q34092684-F3C41ACD-7E27-4156-B307-4CCDA3496EACQ34105027-DF88780A-42DD-4EA5-BBDA-BF0C2822C465Q34110950-1CD67B3F-E3DF-4725-93C8-4CAC081530F5Q34151104-7AC29AB3-0978-456A-8865-79458D045C20Q34151750-B72B1838-BFBA-4FB1-AAE0-181A49C52FBC
P2860
description
1992 nî lūn-bûn
@nan
1992 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1992 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
name
Immunological aspects of demyelinating diseases.
@ast
Immunological aspects of demyelinating diseases.
@en
type
label
Immunological aspects of demyelinating diseases.
@ast
Immunological aspects of demyelinating diseases.
@en
prefLabel
Immunological aspects of demyelinating diseases.
@ast
Immunological aspects of demyelinating diseases.
@en
P2093
P1476
Immunological aspects of demyelinating diseases.
@en
P2093
McFarland HF
McFarlin DE
P304
P356
10.1146/ANNUREV.IY.10.040192.001101
P577
1992-01-01T00:00:00Z